| scholarly article | Q13442814 |
| P356 | DOI | 10.1128/JVI.03713-14 |
| P8608 | Fatcat ID | release_dy5c6syf7zbvhjwr3wejcaroha |
| P932 | PMC publication ID | 4442538 |
| P698 | PubMed publication ID | 25740990 |
| P50 | author | Subhash Verma | Q57951657 |
| Pravinkumar Purushothaman | Q121298588 | ||
| P2093 | author name string | Namrata Gupta | |
| Qiliang Cai | |||
| Suhani Thakker | |||
| Shanthan Challa | |||
| P2860 | cites work | A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients | Q22007941 |
| RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency | Q22009001 | ||
| RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency | Q24315739 | ||
| RFX proteins, a novel family of DNA binding proteins conserved in the eukaryotic kingdom | Q24322587 | ||
| Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cells | Q24527215 | ||
| CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation | Q24551176 | ||
| Associations and interactions between bare lymphocyte syndrome factors | Q24551773 | ||
| Class II transactivator: mastering the art of major histocompatibility complex expression | Q24552298 | ||
| Mutations in the bare lymphocyte syndrome define critical steps in the assembly of the regulatory factor X complex | Q24554195 | ||
| Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y | Q24562002 | ||
| The bare lymphocyte syndrome and the regulation of MHC expression | Q28204378 | ||
| Genetic control of MHC class II expression | Q28216149 | ||
| Mini-review: Specificity and expression of CIITA, the master regulator of MHC class II genes | Q28263358 | ||
| A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome) | Q28301107 | ||
| Expression of the three human major histocompatibility complex class II isotypes exhibits a differential dependence on the transcription factor RFXAP | Q28511541 | ||
| Comprehensive analysis of LANA interacting proteins essential for viral genome tethering and persistence | Q28533244 | ||
| EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors | Q33261811 | ||
| Protein complexes associated with the Kaposi's sarcoma-associated herpesvirus-encoded LANA. | Q33282107 | ||
| Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen inhibits interferon (IFN) beta expression by competing with IFN regulatory factor-3 for binding to IFNB promoter | Q33748042 | ||
| Class II MHC genes: a model gene regulatory system with great biologic consequences | Q33805263 | ||
| Characterization of monoclonal antibodies raised against the latent nuclear antigen of human herpesvirus 8 | Q33814510 | ||
| Transcriptional scaffold: CIITA interacts with NF-Y, RFX, and CREB to cause stereospecific regulation of the class II major histocompatibility complex promoter | Q33965074 | ||
| Upregulation of Cellular Bcl-2 by the KSHV Encoded RTA Promotes Virion Production | Q34013770 | ||
| Monofunctional and polyfunctional CD8+ T cell responses to human herpesvirus 8 lytic and latency proteins | Q34189939 | ||
| Assembly, transport, and function of MHC class II molecules | Q34328789 | ||
| Conserved residues of the bare lymphocyte syndrome transcription factor RFXAP determine coordinate MHC class II expression | Q34474055 | ||
| Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes | Q34593324 | ||
| Function and regulation of class II transactivator in the immune system | Q34630279 | ||
| IRF-4-mediated CIITA transcription is blocked by KSHV encoded LANA to inhibit MHC II presentation | Q35034278 | ||
| Viral inhibition of MHC class II antigen presentation | Q35124245 | ||
| Molecular Biology of Kaposi's Sarcoma-associated Herpesvirus and Related Oncogenesis | Q35124404 | ||
| Structure and function of latency-associated nuclear antigen | Q35124429 | ||
| Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma | Q35131811 | ||
| Molecular biology and pathogenesis of Kaposi sarcoma-associated herpesvirus | Q35138059 | ||
| CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex | Q35192842 | ||
| Kaposi's Sarcoma-Associated Herpesvirus-Encoded Latency-Associated Nuclear Antigen Reduces Interleukin-8 Expression in Endothelial Cells and Impairs Neutrophil Chemotaxis by Degrading Nuclear p65 | Q35192868 | ||
| Two B cell factors bind the HLA-DRA X box region and recognize different subsets of HLA class II promoters | Q35793716 | ||
| Modulation of Immune System by Kaposi’s Sarcoma-Associated Herpesvirus: Lessons from Viral Evasion Strategies | Q35801076 | ||
| Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. | Q35809792 | ||
| Regulatory factor-X binding to mutant HLA-DRA promoter sequences | Q35918019 | ||
| Sequences and factors: a guide to MHC class-II transcription | Q36135151 | ||
| Kaposi's sarcoma-associated herpesvirus inhibits expression and function of endothelial cell major histocompatibility complex class II via suppressor of cytokine signaling 3 | Q36155542 | ||
| A novel antigen-processing-defective phenotype in major histocompatibility complex class II-positive CIITA transfectants is corrected by interferon-gamma | Q36365569 | ||
| Regulation of MHC class II expression, a unique regulatory system identified by the study of a primary immunodeficiency disease. | Q36435823 | ||
| Kaposi's sarcoma and its associated herpesvirus | Q36487309 | ||
| CIITA and Its Dual Roles in MHC Gene Transcription | Q37405448 | ||
| Implication of human herpesviruses in oncogenesis through immune evasion and supression | Q37522705 | ||
| Cytolytic CD4 cells: Direct mediators in infectious disease and malignancy | Q37710793 | ||
| Herpesviruses Placating the Unwilling Host: Manipulation of the MHC Class II Antigen Presentation Pathway | Q38046606 | ||
| The Chromatin Landscape of Kaposi’s Sarcoma-Associated Herpesvirus | Q38108700 | ||
| Gammaherpesviruses and lymphoproliferative disorders | Q38151190 | ||
| Assembly of the RFX complex on the MHCII promoter: role of RFXAP and RFXB in relieving autoinhibition of RFX5. | Q38288080 | ||
| Kaposi's Sarcoma-Associated Herpesvirus-Encoded LANA Recruits Topoisomerase IIβ for Latent DNA Replication of the Terminal Repeats | Q39320195 | ||
| NLRC5 cooperates with the RFX transcription factor complex to induce MHC class I gene expression. | Q39366741 | ||
| The central repeat domain 1 of Kaposi's sarcoma-associated herpesvirus (KSHV) latency associated-nuclear antigen 1 (LANA1) prevents cis MHC class I peptide presentation | Q39591598 | ||
| Major histocompatibility complex class II transcriptional platform: assembly of nuclear factor Y and regulatory factor X (RFX) on DNA requires RFX5 dimers | Q39675159 | ||
| The transcription factor RFX protects MHC class II genes against epigenetic silencing by DNA methylation. | Q39822845 | ||
| Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mimics Epstein-Barr virus EBNA1 immune evasion through central repeat domain effects on protein processing | Q40128647 | ||
| In cis inhibition of antigen processing by the latency-associated nuclear antigen I of Kaposi sarcoma herpes virus | Q40257446 | ||
| The nucleosomal surface as a docking station for Kaposi's sarcoma herpesvirus LANA. | Q40318272 | ||
| Evolutionary conservation and characterization of the bare lymphocyte syndrome transcription factor RFX-B and its paralogue ANKRA2. | Q40469893 | ||
| Kaposi's sarcoma-associated herpesvirus-encoded viral IRF3 modulates major histocompatibility complex class II (MHC-II) antigen presentation through MHC-II transactivator-dependent and -independent mechanisms: implications for oncogenesis | Q40529241 | ||
| Lack of CIITA expression is central to the absence of antigen presentation functions of trophoblast cells and is caused by methylation of the IFN-gamma inducible promoter (PIV) of CIITA. | Q40845871 | ||
| Dissection of functional NF-Y-RFX cooperative interactions on the MHC class II Ea promoter | Q40855305 | ||
| CREB regulates MHC class II expression in a CIITA-dependent manner | Q40968178 | ||
| Regulation of transcription of MHC class II genes | Q41353021 | ||
| Kaposi's Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor 3 Inhibits Gamma Interferon and Major Histocompatibility Complex Class II Expression | Q42059350 | ||
| Solution Structure of the Heterotrimeric Complex between the Interaction Domains of RFX5 and RFXAP from the RFX Gene Regulatory Complex | Q42156320 | ||
| Formation of the RFX gene regulatory complex induces folding of the interaction domain of RFXAP. | Q43107227 | ||
| Successful treatment of post-transplant Kaposi's sarcoma by reduction of immunosuppression. | Q43974311 | ||
| Cellular immune responses and disease control in acute AIDS-associated Kaposi's sarcoma | Q45701411 | ||
| Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells | Q53887653 | ||
| T-cell immunity to Kaposi sarcoma-associated herpesvirus: recognition of primary effusion lymphoma by LANA-specific CD4+ T cells | Q57259563 | ||
| Purified X2 binding protein (X2BP) cooperatively binds the class II MHC X box region in the presence of purified RFX, the X box factor deficient in the bare lymphocyte syndrome | Q71829451 | ||
| The yeast two-hybrid assay to identify interacting proteins | Q73891707 | ||
| A defect in the nuclear translocation of CIITA causes a form of type II bare lymphocyte syndrome | Q74595039 | ||
| Characterization of the RFX complex and the RFX5(L66A) mutant: implications for the regulation of MHC class II gene expression | Q79722457 | ||
| Immune evasion by Kaposi's sarcoma-associated herpesvirus | Q80212464 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | coagulation factor x human | Q28859740 |
| P304 | page(s) | 5536-5556 | |
| P577 | publication date | 2015-03-04 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex | |
| P478 | volume | 89 |
| Q28602577 | Characterization of Yellow Fever Virus Infection of Human and Non-human Primate Antigen Presenting Cells and Their Interaction with CD4+ T Cells |
| Q36646579 | Cytoplasmic isoforms of Kaposi sarcoma herpesvirus LANA recruit and antagonize the innate immune DNA sensor cGAS |
| Q98184110 | Distinct genetic architectures and environmental factors associate with host response to the γ2-herpesvirus infections |
| Q47131669 | Egr-1 regulates RTA transcription through a cooperative involvement of transcriptional regulators |
| Q90702448 | Epigenetic control in Kaposi sarcoma-associated herpesvirus infection and associated disease |
| Q36870503 | G-quadruplex-interacting compounds alter latent DNA replication and episomal persistence of KSHV. |
| Q38817881 | Giving CD4+ T cells the slip: viral interference with MHC class II-restricted antigen processing and presentation. |
| Q49363063 | KSHV LANA upregulates the expression of epidermal growth factor like domain 7 to promote angiogenesis. |
| Q37237030 | KSHV encoded LANA recruits Nucleosome Assembly Protein NAP1L1 for regulating viral DNA replication and transcription |
| Q38692823 | KSHV encoded ORF59 modulates histone arginine methylation of the viral genome to promote viral reactivation |
| Q26742030 | KSHV-Mediated Angiogenesis in Tumor Progression |
| Q38760916 | Major Histocompatibility Complex Class II HLA-DRα Is Downregulated by Kaposi's Sarcoma-Associated Herpesvirus-Encoded Lytic Transactivator RTA and MARCH8. |
| Q90319823 | Molecular Biology of KSHV in Relation to HIV/AIDS-Associated Oncogenesis |
| Q26747452 | The Modulation of Apoptotic Pathways by Gammaherpesviruses |
Search more.